Inari Medical

Nasdaq:  NARI

Filing Date:  02/21/20

Launch Date:  05/18/20

Price Range:  $14.00 - $16.00

Shares Offered (Pre-Shoe, mm):  7.3

Primary Shares (mm):  7.3

Secondary Shares (mm):  0.0

Amount Offered (@ Midpoint)(mm):  $110.0

% Secondary:  0.0%

Shares Outstanding (mm):  46.1

Market Value at IPO Midpoint (mm):  $691.2

Offering as % of Market Value:  15.9%

Active Bookrunners:  Bank of America | Morgan Stanley

Passive Bookrunner:  Wells Fargo

Co-Manager:  Canaccord Genuity

Major Holders:  US Venture Partners | Gilde Healthcare Partners | Versant Venture Partners | Milder Community Property Trust | CVF

Description:  Inari is a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases. Their initial product offering consists of two minimally-invasive, novel catheter-based mechanical thrombectomy devices.

Note:  Emerging Growth Company